logo-loader

Hikma Pharmaceuticals Plc

Receive alerts
Market:
AIM
Market Cap:
£4.58 billion
Price
1,889.50 GBX
Change
-0.03%
52 weeks high
2212.00
52 weeks low
1491.50

In brief

Hikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.